SCHEMBL482114

SCHEMBL482114

[CH2][C@@H]1CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11269 1.00
SCHEMBL321501 1.00
SCHEMBL7191672 0.95
Ammonia Solution, Strong SCHEMBL4643957 0.95
SCHEMBL19897938 0.87
SCHEMBL7232547 0.73
SCHEMBL26278 0.70
SCHEMBL9647703 0.70
SCHEMBL1361148 0.69
SCHEMBL2304373 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 225 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346858-B1 METHODS FOR PREPARING OXAZOLIDINONES AND COMPOSITIONS CONTAINING THEM MERCK SHARP & DOHME (US) 2019-08-07 EP claimed
WO-2008118935-A1 COMPOUNDS AND PROCESSES FOR PREPARING SUBSTITUTED AMINOMETHYL-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-E]INDOL-8-ONES NEUROGEN CORPORATION (US) 2008-10-02 WO claimed
EP-1436258-A4 PH-DEPENDENT NMDA RECEPTOR ANTAGONISTS UNIV EMORY (US) 2005-03-23 EP claimed
US-20040138502-A1 Ph-dependent nmda receptor antagonists EMORY UNIVERSITY 2004-07-15 US claimed
EP-1436258-A2 PH-DEPENDENT NMDA RECEPTOR ANTAGONISTS Emory University (US) 2004-07-14 EP claimed
CN-1134457-C Novel alpha-aminoacetophenone photoinitiators BASF 2004-01-14 CN claimed
WO-2002072542-A2 PH-DEPENDENT NMDA RECEPTOR ANTAGONISTS EMORY UNIVERSITY (US) 2002-09-19 WO claimed
US-20240190837-A1 CARBAZOLE-CONTAINING AMIDES, CARBAMATES, AND UREAS AS CRYPTOCHROME MODULATORS SYCHRONICITY PHARMA INC (US) 2024-06-13 US disclosed
CN-113480438-B Preparation method of esmolol hydrochloride 山东安弘制药有限公司 2024-05-14 CN disclosed
US-20240051951-A1 BICYCLIC COMPOUND AND USE THEREOF SK BIOPHARMACEUTICALS CO., LTD. (KR) 2024-02-15 US disclosed
US-20230416263-A1 CARM1 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2023-12-28 US disclosed
US-11834455-B2 Carm1 inhibitors and uses thereof Epizyme, Inc. (US) 2023-12-05 US disclosed
US-20230286965-A1 BICYCLIC COMPOUND AND USE THEREOF SK BIOPHARMACEUTICALS CO., LTD. (KR) 2023-09-14 US disclosed
CN-1162312-A Phenyloxazolidinone antimicrobials PHARMACIA & UPJOHN CO LLC (US) 1997-10-15 CN disclosed
CN-1160051-A New substituted oxazolidinones BAYER AG (DE) 1997-09-24 CN disclosed
US-5412080-A Enterobactin compounds PRESIDENT AND FELLOW OF HARVARD COLLEGE (US) 1995-05-02 US disclosed
EP-0445026-B1 Aminomethylpiperidine derivatives, their process for preparation and the pharmaceutical compositions containing them ADIR (FR) 1994-01-26 EP disclosed
EP-0445026-A1 Aminomethylpiperidine derivatives, their process for preparation and the pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1991-09-04 EP disclosed
US-4045580-A PHARMACEUTICAL PREPARATION USING 9-(2-HYDROXY-3-AMINO-PROPYL)-9,10-DIHYDRO-9,10-ETHANO-ANTHRACENES AS ANTIDEPRESSANTS CIBA-GEIGY CORPORATION (US) 1977-08-30 US disclosed
US-4017542-A 9-(2-Hydroxy-3-amino-propyl)-9,10-dihydro-9,10-ethano-anthracenes and salts thereof CIBA-GEIGY CORPORATION (US) 1977-04-12 US disclosed